BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mansukhani SA, Hutchinson AK, Neustein R, Schertzer J, Allen JC, Hubbard GB. Fluorescein Angiography in Retinopathy of Prematurity: Comparison of Infants Treated with Bevacizumab to Those with Spontaneous Regression. Ophthalmol Retina 2019;3:436-43. [PMID: 31044736 DOI: 10.1016/j.oret.2019.01.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Rodriguez SH, Schechet SA, Shapiro MJ, Blair MP. Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity. Journal of American Association for Pediatric Ophthalmology and Strabismus 2020;24:149.e1-5. [DOI: 10.1016/j.jaapos.2020.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wood EH, Ji MH, Rao P, Lertjirachai I, Nguyen L, Sbrocca RV, Shah N, Drenser KA. Management of Type 2 Retinopathy of Prematurity or Less in Infants Aged 45 Weeks Postmenstrual Age or Older. Ophthalmic Surg Lasers Imaging Retina 2021;52:636-41. [PMID: 34908484 DOI: 10.3928/23258160-20211031-02] [Reference Citation Analysis]
3 Seery CW, Betesh S, Guo S, Zarbin MA, Bhagat N, Wagner RS. Update on the Use of Anti-VEGF Drugs in the Treatment of Retinopathy of Prematurity. J Pediatr Ophthalmol Strabismus 2020;57:351-62. [PMID: 33211892 DOI: 10.3928/01913913-20200824-02] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Lepore D, Ji MH, Pagliara MM, Lenkowicz J, Capocchiano ND, Tagliaferri L, Boldrini L, Valentini V, Damiani A; FA Team of the Italian ROP Study Group. Convolutional Neural Network Based on Fluorescein Angiography Images for Retinopathy of Prematurity Management. Transl Vis Sci Technol 2020;9:37. [PMID: 32855841 DOI: 10.1167/tvst.9.2.37] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hložánek M, Straňák Z, Terešková Z, Mareš J, Krejčířová I, Česká Burdová M. Trends in Neonatal Ophthalmic Screening Methods. Diagnostics 2022;12:1251. [DOI: 10.3390/diagnostics12051251] [Reference Citation Analysis]
6 Bayramoglu SE, Sayin N. The effect of intravitreal bevacizumab dose on retinal vascular progression in retinopathy of prematurity. Ophthalmologica 2021. [PMID: 34844257 DOI: 10.1159/000521070] [Reference Citation Analysis]
7 Bayramoglu SE, Sayin N. Inter-eye comparison of retinal vascular growth rate and angiographic findings following unilateral bevacizumab treatment. Eur J Ophthalmol 2021;:11206721211064019. [PMID: 34851169 DOI: 10.1177/11206721211064019] [Reference Citation Analysis]
8 Wang L, Li M, Zhu J, Yan H, Wu L, Fan J, Zhou Y, Gou K, Zhang Z, Wang Y. Clinical Features of Spontaneous Regression of Retinopathy of Prematurity in China: A 5-Year Retrospective Case Series. Front Med (Lausanne) 2021;8:731421. [PMID: 34532335 DOI: 10.3389/fmed.2021.731421] [Reference Citation Analysis]
9 Mansukhani SA, Hutchinson AK, Hubbard GB. Reply. Ophthalmol Retina 2020;4:e1-2. [PMID: 31902474 DOI: 10.1016/j.oret.2019.09.013] [Reference Citation Analysis]
10 Agarwal K, Vinekar A, Chandra P, Padhi TR, Nayak S, Jayanna S, Panchal B, Jalali S, Das T. Imaging the pediatric retina: An overview. Indian J Ophthalmol 2021;69:812-23. [PMID: 33727440 DOI: 10.4103/ijo.IJO_1917_20] [Reference Citation Analysis]
11 Lepore D, Ji MH, Ying GS, Orazi L, Pagliara MM, Quinn GE; FA team of the Italian ROP study Group. Early angiographic signs of retinopathy of prematurity requiring treatment. Eye (Lond) 2021;35:3094-101. [PMID: 33469135 DOI: 10.1038/s41433-020-01305-z] [Reference Citation Analysis]
12 Bayramoglu SE, Sayın N. Fluorescein Angiography Findings in Treatment-Naive Premature Infants with Retinal Vascular Immaturity and Persistent Avascular Retina. Semin Ophthalmol 2022;:1-9. [PMID: 35671203 DOI: 10.1080/08820538.2022.2085518] [Reference Citation Analysis]
13 Cai S, Therattil A, Vajzovic L. Recent developments in pediatric retina. Current Opinion in Ophthalmology 2020;31:155-60. [DOI: 10.1097/icu.0000000000000650] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Celiker H, Sahin O. Angiographic findings in cases with a history of severe retinopathy of prematurity treated with anti-VEGFs: Follow-up to age 6 years. Int Ophthalmol 2021. [PMID: 34729633 DOI: 10.1007/s10792-021-02119-y] [Reference Citation Analysis]
15 Carroll L, Owen LA. Current evidence and outcomes for retinopathy of prematurity prevention: insight into novel maternal and placental contributions. Explor Med 2020;1:4-26. [PMID: 32342063 DOI: 10.37349/emed.2020.00002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
16 Chen X, Imperio R, Seely KR, Viehland C, Izatt JA, Prakalapakorn SG, Freedman SF, Toth CA. Slow progressive perifoveal vascular formation in an infant with aggressive posterior retinopathy of prematurity. J AAPOS 2020;24:323-6. [PMID: 33045380 DOI: 10.1016/j.jaapos.2020.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Vural A, Demirayak B, Ozbas M, Onur IU, Celik G. Comparison of Fluorescein Angiography Findings in Stage 3 Retinopathy of Prematurity in Zone II Treated With or Without Anti-VEGF. Eur J Ophthalmol 2022;:11206721221076691. [PMID: 35191353 DOI: 10.1177/11206721221076691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Barry GP, Yu Y, Ying GS, Tomlinson LA, Lajoie J, Fisher M, Binenbaum G; G-ROP Study Group. Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti-Vascular Endothelial Growth Factor. Ophthalmology 2021;128:1188-96. [PMID: 33387554 DOI: 10.1016/j.ophtha.2020.12.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Huang Q, Xu Y, Zhang Q, Lyu J, Chen S, Zhao P. Peripheral Vascular Abnormalities Detected by Fluorescein Angiography in Contralateral Eyes of Patients With Persistent Fetal Vasculature. Ophthalmic Surg Lasers Imaging Retina 2020;51:506-11. [PMID: 32955590 DOI: 10.3928/23258160-20200831-05] [Reference Citation Analysis]
20 Ji MH, Moshfeghi DM, Shields RA, Bodnar Z, Ludwig CA, Callaway NF, Orazi L, Amorelli GM, Lepore D. Conserved regression patterns of retinopathy of prematurity after intravitreal ranibizumab: A class effect. Eur J Ophthalmol 2021;31:2135-40. [PMID: 32722932 DOI: 10.1177/1120672120945101] [Reference Citation Analysis]
21 Wagner RS. Fluorescein Angiography in the Management of Retinopathy of Prematurity. J Pediatr Ophthalmol Strabismus 2019;56:213. [PMID: 31322709 DOI: 10.3928/01913913-20190613-01] [Reference Citation Analysis]
22 Gunay M, Tugcugil E, Somuncu AM, Kola M, Turk A, Uzlu D, Kose B, Erdol H. The clinical use of ultra - Wide field imaging and intravenous fluorescein angiography in infants with retinopathy of prematurity. Photodiagnosis Photodyn Ther 2021;37:102658. [PMID: 34844001 DOI: 10.1016/j.pdpdt.2021.102658] [Reference Citation Analysis]
23 Sternfeld A, Rahmani S, Rossen JL, Zhang DL, Li YD, Quan VL, Huang R, Yoon HH. Long-term retinal vasculature abnormalities following intravitreal bevacizumab for retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2021. [PMID: 34851464 DOI: 10.1007/s00417-021-05499-0] [Reference Citation Analysis]